Plasma riche en plaquettes appliqué au dermapen (microneedling), 4 séances face à Plasma riche en plaquettes en injections point par point, 4 séances

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008* BT 44.03±16.20 55.99±15.97 0.005a* AT 50.55±17.92 49.99±19.72 0.908a pb 0.076 0.046* BT 55.96±16.20 44.01±15.97 0.005a* AT 49.32±18.10 50.01±19.72 0.887a Wiley pb 0.070 0.046* Online BT 0.67±0.13 0.84±0.22 0.001a* Library AT 0.75±0.19 0.77±0.23 0.702a pb on 0.044* 0.106 [03/11/2022]. BT 6.66±7.27(3.7) 5.78±5.77(3.7) 0.909c AT 8.0±8.6(5.5) 8.28±8.27(5.5) 0.821c See pd 0.476 0.063 the 0.657a Terms BT 41.33±25.61 44.26±26.05 AT 48.42±25.40 49.35±28.62 0.893a and Conditions pb 0.013* 0.012*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008* BT 44.03±16.20 55.99±15.97 0.005a* AT 50.55±17.92 49.99±19.72 0.908a pb 0.076 0.046* BT 55.96±16.20 44.01±15.97 0.005a* AT 49.32±18.10 50.01±19.72 0.887a Wiley pb 0.070 0.046* Online BT 0.67±0.13 0.84±0.22 0.001a* Library AT 0.75±0.19 0.77±0.23 0.702a pb on 0.044* 0.106 [03/11/2022]. BT 6.66±7.27(3.7) 5.78±5.77(3.7) 0.909c AT 8.0±8.6(5.5) 8.28±8.27(5.5) 0.821c See pd 0.476 0.063 the 0.657a Terms BT 41.33±25.61 44.26±26.05 AT 48.42±25.40 49.35±28.62 0.893a and Conditions pb 0.013* 0.012*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008* BT 44.03±16.20 55.99±15.97 0.005a* AT 50.55±17.92 49.99±19.72 0.908a pb 0.076 0.046*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

TABLE 3 Intergroupandingroup evaluationoftrichoscanparameters Haircount Hairdensity Anagenhair Telogenhair Averagehairlength Vellushairdensity Terminalhairdensity Vellushaircount Terminalhaircount Vellushairratio Terminalhairratio 15298019, 5of7 2022, Dermapen Pointbypoint 1, Downloaded Mean±SD Mean±SD p BT 26.26±17.17 27.39±16.63 0.793a from AT 30.85±17.51 31.53±18.61 0.884a https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, pb 0.014* 0.008* BT 48±31.37 50.06±30.40 0.794a AT 56.39±31.95 57.64±34.02 0.882a pb 0.013* 0.008* BT 44.03±16.20 55.99±15.97 0.005a* AT 50.55±17.92 49.99±19.72 0.908a pb 0.076 0.046*

Citation complémentaire (significativite)

TABLE 4 Intergroupevaluationof 1, thechangeintrichoscanparametersafter Downloaded Mean±SD(median) Mean±SD(median) p treatmentcomparedtobeforetreatment Haircount 4.60±9.76(4.5) 4.14±8.04(5.5) 0.838 from Hairdensity 8.39±17.78(8.3) 7.57±14.71(10) 0.833 https://onlinelibrary.wiley.com/doi/10.1111/dth.15182, Anagenhair 6.52±19.74(2.2) (cid:1)6.0±16.06((cid:1)4.4) 0.016* Telogenhair (cid:1)6.65±19.73((cid:1)2.2) 6.0±16.06(4.4) 0.014* Averagehairlength 0.08±0.21(0.06) (cid:1)0.06±0.21((cid:1)0.06) 0.018* Vellushairdensity 1.33±6.48(0) 2.5±7.29(0.9) 0.283 Terminalhairdensity 7.09±14.91(8.3) 5.09±10.58(6.4) 0.477 Vellushaircount 0.73±3.54(0) 1.37±3.99(0.5) 0.267 Terminalhaircount 4.02±8.06(4.5) 2.77±5.78(3.5) 0.438 Vellushairdensity 0.55±10.18(0) 2.4±12.16(0) 0.410 Terminalhairdensity (cid:1)0.55±10.18(0) (cid:1)2.4±12.16(0) 0.410 Note:Mann–WhitneyUTest.

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

didnotyieldanystatisticallysignificantdifference(p>0.05).Thetest See resultwaspositivein67.7%ofthecasesindermapenand87.1%of the the point-by-point injection group. The post-treatment hair pull test Terms results were similar between two study groups (p>0.05). The test and result was negative in 87.1% of the dermapen and in 77.4%

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).

didnotyieldanystatisticallysignificantdifference(p>0.05).Thetest See resultwaspositivein67.7%ofthecasesindermapenand87.1%of the the point-by-point injection group. The post-treatment hair pull test Terms results were similar between two study groups (p>0.05). The test and result was negative in 87.1% of the dermapen and in 77.4%

Ozcan KN, Sener S, Altunisik N et al.. Platelet rich plasma application by dermapen microneedling and intradermal point-by-point injection methods, and their comparison with clinical findings and trichoscan in patients with androgenetic alopecia.. Dermatol Ther 2022, DOI 10.1111/dth.15182. Citation reproduite au titre du droit de courte citation (article L122-5 du Code de la propriété intellectuelle).